US closer to approval of 'biosimilar' from Korea

US closer to approval of 'biosimilar' from Korea

Korean biomedicine company Celltrion's copy of Johnson & Johnson's best-selling rheumatoid arthritis treatment Remicade received Tuesday a critical recommendation for approval from advisers to the U.S. Food and Drug Administration. The lower-cost …

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.